mifepristone has been researched along with Binge Alcohol Consumption in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauder, M; Crabbe, JC; Hack, WR; Hausch, F; Hunt, H; LeMoine, K; Metten, P; Ozburn, AR; Savarese, AM; Schlumbohm, JP | 1 |
| Brunnquell, M; Cippitelli, A; Damadzic, R; Eskay, RL; Hamelink, C; Heilig, M; Thorsell, A | 1 |
2 other study(ies) available for mifepristone and Binge Alcohol Consumption
| Article | Year |
|---|---|
Targeting the Glucocorticoid Receptor Reduces Binge-Like Drinking in High Drinking in the Dark (HDID-1) Mice.
Topics: Alcohol Drinking; Animals; Aversive Agents; Binge Drinking; Ethanol; Female; Isoquinolines; Male; Mice; Mifepristone; Pyrazoles; Receptors, Glucocorticoid; Tacrolimus Binding Proteins | 2020 |
Binge-like ethanol consumption increases corticosterone levels and neurodegneration whereas occupancy of type II glucocorticoid receptors with mifepristone is neuroprotective.
Topics: Adrenalectomy; Alcohol-Induced Disorders, Nervous System; Alcoholic Intoxication; Analysis of Variance; Animals; Binge Drinking; Cholesterol; Corticosterone; Dentate Gyrus; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Implants; Entorhinal Cortex; Ethanol; Fluoresceins; Hormone Antagonists; Hypothalamo-Hypophyseal System; Male; Mifepristone; Neuroprotective Agents; Pituitary-Adrenal System; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Silver Staining; Stress, Physiological | 2014 |